Capricor Therapeutics Eulerpool News

Capricor Therapeutics Eulerpool News

Capricor Therapeutics Aktie News

Capricor Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Capricor Therapeutics News stellen wir hier zusammen.

• 29. April ·

  TipRanks
  Capricor Therapeutics Updates on Duchenne Treatment Progress
• 27. April ·

  TipRanks
  Buy Rating Affirmed for Capricor Therapeutics Amidst Positive FDA Discussions and Clinical Advancements
• 25. April ·

  TipRanks
  Optimistic Outlook for Capricor Therapeutics: Buy Rating Affirmed Amid Regulatory Progress and Strong Financial Position
• 24. April ·

  Yahoo
  Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
• 24. April ·

  Yahoo
  Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
• 24. April ·

  Seeking Alpha
  Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers
• 24. April ·

  Thefly.com
  Capricor Therapeutics announces Type B meeting with FDA for CAP-1002 program
• 23. April ·

  Seeking Alpha
  Edgewise gets EU orphan drug status for muscular dystrophy drug
• 10. April ·

  Yahoo
  Wall Street Analysts Predict a 218.18% Upside in Capricor (CAPR): Here's What You Should Know
• 1. April ·

  Seeking Alpha
  Solid Biosciences gets FDA rare pediatric disease status for DMD therapy